Rising popularity of precision medicines to drive the global cell isolation market growth until 2026.
According to TechSci Research report, “Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Filtration-Based Cell Isolation, Surface Marker-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others), By End-User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks), By Region, Forecast & Opportunities, 2026”, global cell isolation market was valued at USD7013.71 million in 2020 and is anticipated to reach USD15529.45 million by 2026 by registering a growing CAGR of 15.25%. Cell isolation is a procedure to isolate the desired cells from the given samples and is considered to be an essential tool in the research and development of a particular type of cell. Cell isolation technique finds application in the manufacture of drugs, vaccines, enzymes, antibodies, protein and other products. The surge in the demand for these products has led to the market growth on a global level. The market is gaining traction due to the rising number of patients suffering from cancer and other infectious diseases. Cell isolation is an efficient technique for cancer and other diseases that focuses on separating and treating a particular type of cell. Furthermore, rising popularity of personalized medicines or precision medicines is also propelling the market growth. Precision medicines are the medicines that provide customized treatment to patients based on the patient’s body requirements. These requirements are analyzed with the help of cell isolation techniques. Increasing investments of the government and biotechnology-based companies in cell-based operations and stem cell research are some factors boosting the market growth. Furthermore, rising consumer awareness regarding different advanced treatment techniques has also worked in the favor of the market growth.
Browse 186 Figures spread through 110 Pages and an in-depth TOC on “Global Cell Isolation Market”
Global cell isolation market is segmented into product, cell type, source, technique, application, end-user, company and region. Based on product, the market is further bifurcated into consumables and instruments, out of which, consumables held the largest share in 2020 on account of rising investments by companies and the improving research and development activities by biotechnology companies on cell isolation techniques. On the other hand, instruments segment is expected to register a high growth due to product advancements in the healthcare sector. Based on cell type, the market is bifurcated into human cells and animal cells. Amongst these, human cells segment held the largest market share in 2020 and is further expected to maintain its leading position in the market in the next five years as well on account of rising popularity of precision medicines and growing focus of biopharmaceutical companies on human stem cell research and cancer treatments. However, animal cells segment is expected to grow faster during the forecast period on account of rising government initiatives towards novel drug discoveries. Based on end user, the market is categorized into research laboratories and institutes, biotechnology and biopharmaceutical companies, cell banks, hospitals & diagnostic laboratories. Out of which, biotechnology and biopharmaceutical companies dominated the market in 2020 by holding 42.88% of the market share which can be ascribed to high adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5108
Customers can also request for 10% free customization on this report.
Some of the leading players in global cell isolation market include GE Healthcare Inc., Stemcell Technologies Inc., Danaher Corporation (Beckman Coulter Inc.), Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Sartorius AG, Cell Biolabs Inc., Miltenyi Biotec GmbH, F. Hoffmann-La Roche AG, Corning Inc, Akadeum Life Sciences, Inc., Invent Biotechnologies, Inc., and others.
“Based on regional analysis, North America held the major share in the market in 2020 by virtue of the investments made by the government to support the expansion of biopharma industry and enhance the R&D activities for stem cell research and cancer treatment. Surge in the number of patients suffering from chronic diseases is also contributing to the growth of the market. North America is followed by Europe in terms of market share, as the market is driven by the essential life sciences research being carried out in the region,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Filtration-Based Cell Isolation, Surface Marker-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others), By End-User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global cell isolation market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global cell isolation market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017